⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7161283 | 0.75 | — | — | |
| SCHEMBL7161276 | 0.75 | — | — | |
| SCHEMBL18140270 | 0.74 | TDP1 (0.32) | — | |
| SCHEMBL5549439 | 0.72 | TP53 (0.36) | — | |
| SCHEMBL17938008 | 0.72 | TP53 (0.36) | — | |
| SCHEMBL5212996 | 0.71 | — | — | |
| SCHEMBL7109897 | 0.71 | TSHR (0.33) | — | |
| SCHEMBL14280294 | 0.70 | TSHR (0.31) | — | |
| SCHEMBL11490831 | 0.70 | TSHR (0.31) | — | |
| SCHEMBL28033169 | 0.70 | LMNA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410262-B2 | Peptide conjugates of cytotoxins as therapeutics | Cybrexa 2, Inc. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20240010755-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. | 2024-01-11 | — | — | US | disclosed |
| US-11634508-B2 | Peptide conjugates of cytotoxins as therapeutics | Cybrexa 2, Inc. (US) | 2023-04-25 | — | — | US | disclosed |
| US-11634508-B2 | Peptide conjugates of cytotoxins as therapeutics | Cybrexa 2, Inc. (US) | 2023-04-25 | — | — | US | disclosed |
| EP-3997093-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. (US) | 2022-05-18 | — | — | EP | disclosed |
| CN-114341162-A | Peptide conjugates of cytotoxins as therapeutic agents | 赛博克萨2公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20210009719-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. | 2021-01-14 | — | — | US | disclosed |